<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2</volume><submitter>Kim MM</submitter><funding>Natural Sciences and Engineering Research Council (NSERC) of Canada</funding><pubmed_abstract>Substitution of serum and other clinically incompatible reagents is requisite for controlling product quality in a therapeutic cell manufacturing process. However, substitution with chemically defined compounds creates a complex, large-scale optimization problem due to the large number of possible factors and dose levels, making conventional process optimization methods ineffective. We present a framework for high-dimensional optimization of serum-free formulations for the expansion of human hematopoietic cells. Our model-free approach utilizes evolutionary computing principles to drive an experiment-based feedback control platform. We validate this method by optimizing serum-free formulations for first, TF-1 cells and second, primary T-cells. For each cell type, we successfully identify a</pubmed_abstract><journal>Communications biology</journal><pagination>48</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6358607</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>On-demand serum-free media formulations for human hematopoietic cell expansion using a high dimensional search algorithm.</pubmed_title><pmcid>PMC6358607</pmcid><pubmed_authors>Kim MM</pubmed_authors><pubmed_authors>Audet J</pubmed_authors></additional><is_claimable>false</is_claimable><name>On-demand serum-free media formulations for human hematopoietic cell expansion using a high dimensional search algorithm.</name><description>Substitution of serum and other clinically incompatible reagents is requisite for controlling product quality in a therapeutic cell manufacturing process. However, substitution with chemically defined compounds creates a complex, large-scale optimization problem due to the large number of possible factors and dose levels, making conventional process optimization methods ineffective. We present a framework for high-dimensional optimization of serum-free formulations for the expansion of human hematopoietic cells. Our model-free approach utilizes evolutionary computing principles to drive an experiment-based feedback control platform. We validate this method by optimizing serum-free formulations for first, TF-1 cells and second, primary T-cells. For each cell type, we successfully identify a</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2026-05-07T06:24:38.71Z</modification><creation>2019-03-26T22:50:52Z</creation></dates><accession>S-EPMC6358607</accession><cross_references><pubmed>30729186</pubmed><doi>10.1038/s42003-019-0296-7</doi></cross_references></HashMap>